PennyToBuck.com Stock Report On PWRM,SNY- Power 3 Medical Products, Sanofi-Aventis

***********************************

PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

** THE INTERNATIONAL CONGRESS OF ALZHEIMER'S DISEASE ACCEPTS FOUR SCIENTIFIC PRESENTATIONS BY PWRM **

Four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the PWRM's NuroPro AD biomarkers and blood test for Alzheimer's disease.

The four studies to be presented involve a total of 154 Alzheimer's disease patients and 91 Parkinson's disease patients, as well as 210 age-matched normal control individuals and 173 disease control individuals.

- According to recent estimates, as many as 2.4 million to 4.5 million Americans have Alzheimer's disease (AD). Unless the disease can be effectively treated or prevented, the number of people with AD will increase significantly if current population trends continue. That's because the risk of AD increases with age, and the U.S. population is aging. The number of people age 65 and older is expected to grow from 39 million in 2008 to 72 million in 2030, and the number of people with AD doubles for every 5-year interval beyond age 65. (Source: CLICK HERE)

Furthermore, PWRM recently has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro protein biomarkers in the blood of untreated Alzheimer's disease patients compared to patients treated with the widely used anti-dementia drugs AriceptSimilar Topic Blog Posts :

• Pwrm,icad,jaso Stock Report From Pennytobuck.com Posted By: Bill ...
• Love Diabetes: The blasphemy of C-peptide Removal « Type 1 Diabetic